3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Leukemia, Myeloid, Acute
17
Leukemia, Promyelocytic, Acute
10
Leukemia
9
Myelodysplastic Syndromes
8
Melanoma
5
Congenital Abnormalities
4
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
3
Multiple Myeloma
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Erythroblastic, Acute
3
Uterine Cervical Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neuroblastoma
2
Lymphoma, T-Cell, Cutaneous
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uterine Cervical Dysplasia
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Neoplasm Metastasis
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Interventions
Gemcitabine
74
Capecitabine
60
Paclitaxel
59
Fluorouracil
58
Oxaliplatin
57
Bevacizumab
51
Docetaxel
50
Leucovorin
48
Nivolumab
40
Cisplatin
40
Irinotecan
39
Carboplatin
37
Cetuximab
34
pembrolizumab
32
Radiosurgery
32
Trastuzumab
30
Radiotherapy
27
Everolimus
24
Sorafenib
23
Pemetrexed
20
Doxorubicin
20
Albumin-Bound Paclitaxel
20
Ipilimumab
19
Cyclophosphamide
19
Panitumumab
18
Zoledronic Acid
17
Lapatinib
17
Erlotinib Hydrochloride
17
Prednisone
16
pazopanib
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasm Metastasis
×
Tretinoin
×
Clear all
NCT03307148
2020-01-22
STAR_PAC
Barts & The London NHS Trust
Phase 1
Completed
29 enrolled